Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Toxicity Assessment of [177Lu]Lu-iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes.
Nanomaterials (Basel). 2022 Nov 25;12(23):4181. doi: 10.3390/nano12234181.
Nanomaterials (Basel). 2022.
PMID: 36500804
Free PMC article.
225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins.
Hernández-Jiménez T, Ferro-Flores G, Morales-Ávila E, Isaac-Olivé K, Ocampo-García B, Aranda-Lara L, Santos-Cuevas C, Luna-Gutiérrez M, De Nardo L, Rosato A, Meléndez-Alafort L.
Hernández-Jiménez T, et al.
Molecules. 2022 Mar 27;27(7):2156. doi: 10.3390/molecules27072156.
Molecules. 2022.
PMID: 35408554
Free PMC article.
Item in Clipboard
Targeted Endoradiotherapy with Lu2O3-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image.
Luna-Gutiérrez M, Ocampo-García B, Jiménez-Mancilla N, Ancira-Cortez A, Trujillo-Benítez D, Hernández-Jiménez T, Ramírez-Nava G, Hernández-Ramírez R, Santos-Cuevas C, Ferro-Flores G.
Luna-Gutiérrez M, et al. Among authors: hernandez jimenez t.
Pharmaceutics. 2022 Mar 27;14(4):720. doi: 10.3390/pharmaceutics14040720.
Pharmaceutics. 2022.
PMID: 35456554
Free PMC article.
Item in Clipboard
Cite
Cite